Home About Us Partners Contact Us
 
Representative Technologies

Pharmaceuticals

  Composition / Molecule (API)
  Formulation
  Dosage form (e.g., IR tablets/capsules, ER/MR/DR tablets/capsules, transdermals, injectables)
  Method of manufacture
  Method of treatment
  Method of use
  Racemate and enantiomer
  Impurities and related compounds in the API
  Intermediates used in making the API
  Process patents for making the API/formulation
  Polymorphic forms and particle size of API
  Formulations (immediate, delayed, extended)
  Pharmacokinetics (AUC, Tmax, Cmax), dissolution profile, dosage form characteristics (e.g., improved bioavailability, improved taste profile, food effect)
  Combination of two active ingredients

 

Medical Devices

  Robotic radiosurgery systems
  Cardiac defibrillators
  Stents
  Drug-eluting stents
  Medical fluid injectors
  Implantable cardiac devices

Biologics

  Radiolabeled antibodies
  Recombinant cloning vehicles
  Methods of microbial expression of polypeptides
  Method for inhibiting cell growth control factors
  Recombinant erythropoietin
  Enoxaparin sodium

 

Biosimilars

  Composition - proteins, DNA, antibodies
  Formulation
  Protein purification/downstream processing
  Method of administration
  Method of treatment
  Dosage form (e.g., IV/Subcutaneous)

 

Combination Products

  Drug-drug
  Drug-medical device
  Drug-biologics
  Biologics-medical device

 

Bioinformatics

 
Disclaimer | Jellins Christensen, LLP © 2016 All Rights Reserved